Open AccessTwelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients
Author(s) -
Nicolás Manito,
Juan Delgado,
María G. CrespoLeiro,
José M. Arizón,
Javier Segovia,
Francisco González-Vı́lchez,
Sònia Mirabet,
E. Lage,
Domingo A. PascualFigal,
Beatriz Díaz,
Jesús Palomo,
Gregorio Rábago,
Marina de Benito Sanz,
Teresa Blasco,
Eulàlia Roig
Publication year - 2015
Publication title -
world journal of transplantation
Language(s) - English
Resource type - Journals
ISSN - 2220-3230
DOI - 10.5500/wjt.v5.i4.310
Subject(s) - calcineurin , medicine , everolimus , nephrotoxicity , urology , heart transplantation , creatinine , tacrolimus , gastroenterology , transplantation , surgery , toxicity
To determine the clinical reasons for conversion to everolimus (EVL) and long-term outcomes in heart transplant (HT) recipients.